Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viktor Brabec

Showing results (151-160 of 242) with videos related to

Pageof 25
Sort By:
Biochemical Pharmacology|April 19, 2015
New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cellsVojtech Novohradsky, Lenka Zerzankova, Jana Stepankova, et al.
Biochemistry|February 5, 2003
Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 proteinJana Kasparkova, Olivier Delalande, Michal Stros, et al.
Biochemical Pharmacology|March 10, 2004
DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligandRadim Prokop, Jana Kasparkova, Olga Novakova, et al.
Molecular Pharmaceutics|May 18, 2012
Valuable insight into the anticancer activity of the platinum-histone deacetylase inhibitor conjugate, cis-[Pt(NH3)2malSAHA-2H)]Viktor Brabec, Darren M Griffith, Anna Kisova, et al.
Dalton Transactions (Cambridge, England : 2003)|October 4, 2017
Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNAJana Kasparkova, Hana Kostrhunova, Vojtech Novohradsky, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 19, 2025
Cisplatin-eugenol Pt(IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacyVojtech Novohradsky, Tomer Babu, Hana Kostrhunova, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 1, 2020
Antiproliferative, DNA binding, and cleavage properties of dinuclear Co(III) complexes containing the bioactive quinizarin ligandHana Crlikova, Hana Kostrhunova, Jitka Pracharova, et al.
European Journal of Medicinal Chemistry|March 29, 2014
Conformation and recognition of DNA damaged by antitumor cis-dichlorido platinum(II) complex of CDK inhibitor bohemineOlga Novakova, Barbora Liskova, Jana Vystrcilova, et al.
Chemical Science|July 13, 2018
Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of actionRaji Raveendran, Jeremy Phillip Braude, Ezequiel Wexselblatt, et al.
Journal of Inorganic Biochemistry|February 2, 2008
Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamineAnna Halámiková, Pavla Heringová, Jana Kaspárková, et al.
Pageof 25

Showing results (151-160 of 242) with videos related to

Sort By:
Pageof 25
Biochemical Pharmacology|April 19, 2015
New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cellsVojtech Novohradsky, Lenka Zerzankova, Jana Stepankova, et al.
Biochemistry|February 5, 2003
Recognition of DNA interstrand cross-link of antitumor cisplatin by HMGB1 proteinJana Kasparkova, Olivier Delalande, Michal Stros, et al.
Biochemical Pharmacology|March 10, 2004
DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligandRadim Prokop, Jana Kasparkova, Olga Novakova, et al.
Molecular Pharmaceutics|May 18, 2012
Valuable insight into the anticancer activity of the platinum-histone deacetylase inhibitor conjugate, cis-[Pt(NH3)2malSAHA-2H)]Viktor Brabec, Darren M Griffith, Anna Kisova, et al.
Dalton Transactions (Cambridge, England : 2003)|October 4, 2017
Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNAJana Kasparkova, Hana Kostrhunova, Vojtech Novohradsky, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 19, 2025
Cisplatin-eugenol Pt(IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacyVojtech Novohradsky, Tomer Babu, Hana Kostrhunova, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 1, 2020
Antiproliferative, DNA binding, and cleavage properties of dinuclear Co(III) complexes containing the bioactive quinizarin ligandHana Crlikova, Hana Kostrhunova, Jitka Pracharova, et al.
European Journal of Medicinal Chemistry|March 29, 2014
Conformation and recognition of DNA damaged by antitumor cis-dichlorido platinum(II) complex of CDK inhibitor bohemineOlga Novakova, Barbora Liskova, Jana Vystrcilova, et al.
Chemical Science|July 13, 2018
Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of actionRaji Raveendran, Jeremy Phillip Braude, Ezequiel Wexselblatt, et al.
Journal of Inorganic Biochemistry|February 2, 2008
Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamineAnna Halámiková, Pavla Heringová, Jana Kaspárková, et al.
Pageof 25